Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic.

Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15

Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy. Am J Gastroenterol (2009) 1.62

Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients. Gastroenterology (2007) 1.16

"The cancer bond": exploring the formation of cancer risk perception in families with Lynch syndrome. J Genet Couns (2010) 0.91

Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families. J Med Genet (2005) 0.88

Germline mutation analysis of hPMS2 gene in Chinese families with hereditary nonpolyposis colorectal cancer. World J Gastroenterol (2010) 0.85

Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion. Mol Cancer (2013) 0.85

Prediction models in Lynch syndrome. Fam Cancer (2013) 0.84

Evidence of linkage to chromosomes 10p15.3-p15.1, 14q24.3-q31.1 and 9q33.3-q34.3 in non-syndromic colorectal cancer families. Eur J Hum Genet (2011) 0.82

MTHFR C677T and A1298C variant genotypes and the risk of microsatellite instability among Iranian colorectal cancer patients. Cancer Genet Cytogenet (2010) 0.81

Novel hMSH2, hMSH6 and hMLH1 gene mutations and microsatellite instability in sporadic colorectal cancer. J Cancer Res Clin Oncol (2006) 0.80

hMLH1 promoter methylation and BRAF mutations in high-frequency microsatellite instability colorectal cancers not fulfilling the revised Bethesda guidelines. Ann Surg Treat Res (2014) 0.79

The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative. Carcinogenesis (2012) 0.79

Are prediction models for Lynch syndrome valid for probands with endometrial cancer? Fam Cancer (2009) 0.78

Lynch syndrome in Tunisia: first description of clinical features and germline mutations. Int J Colorectal Dis (2011) 0.77

Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR. J Comp Eff Res (2015) 0.76

Development of multidisciplinary committees for decision making and care management in hereditary colon cancer: the French state of the art. J Community Genet (2013) 0.75

Association of a novel point mutation in MSH2 gene with familial multiple primary cancers. J Hematol Oncol (2017) 0.75

Thyroid cancer in a patient with Lynch syndrome - case report and literature review. Ther Clin Risk Manag (2017) 0.75

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (1999) 13.19

BLOOD CHEMICAL CHANGES IN BOECK'S SARCOID WITH PARTICULAR REFERENCE TO PROTEIN, CALCIUM AND PHOSPHATASE VALUES. J Clin Invest (1939) 9.81

Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet (2001) 7.27

Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science (1997) 6.66

Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet (2003) 5.39

Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet (1998) 4.72

Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science (1997) 4.55

Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet (2005) 4.12

Lactic acidosis complicating the acquired immunodeficiency syndrome. Ann Intern Med (1993) 4.08

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science (1989) 3.47

Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer (2011) 3.23

PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet (1999) 3.22

Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut (2010) 3.22

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet (2008) 2.81

The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med (1999) 2.76

TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Gut (2011) 2.75

Cervical sampling devices. BMJ (1996) 2.74

Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut (2008) 2.65

Sentinel node biopsy in cutaneous melanoma: time for consensus to better inform patient choice. Br J Dermatol (2015) 2.61

Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int (1979) 2.45

Parental modeling and parenting behavior effects on offspring alcohol and cigarette use. A growth curve analysis. J Subst Abuse (2000) 2.44

Effect of smoking cessation on cervical lesion size. Lancet (1996) 2.35

A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess (1999) 2.32

Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J Biol Chem (1997) 2.28

Trends in cervical cancer mortality. Lancet (1991) 2.28

The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sci U S A (1998) 2.27

Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science (1996) 2.22

Severe fetal asphyxia associated with neuropathology. Am J Obstet Gynecol (1996) 2.08

Two cases of X/autosome translocation in females with incontinentia pigmenti. Hum Genet (1985) 2.05

Development of a compact fast CCD camera and resonant soft x-ray scattering endstation for time-resolved pump-probe experiments. Rev Sci Instrum (2011) 2.05

Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet (2003) 2.04

Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch Biochem Biophys (1989) 1.96

Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology (1997) 1.96

Accelerated decline in cervical cancer mortality in England and Wales. Lancet (1995) 1.95

Manganese transport in Bacillus subtilis W23 during growth and sporulation. J Bacteriol (1973) 1.91

Narrow band imaging for colonoscopic surveillance in hereditary non-polyposis colorectal cancer. Gut (2007) 1.90

Hypnosis or cognitive behavioral training for the reduction of pain and nausea during cancer treatment: a controlled clinical trial. Pain (1992) 1.88

Radioimmunotherapy with iodine (131)I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience. Blood (2000) 1.84

Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet (2001) 1.81

APC in the regulation of intestinal crypt fission. J Pathol (1998) 1.73

Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant (1993) 1.72

Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer (1996) 1.71

Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. J Clin Oncol (1996) 1.70

Fanconi anaemia. J Med Genet (2003) 1.70

Secondary and tertiary structures of hyaluronan in aqueous solution, investigated by rotary shadowing-electron microscopy and computer simulation. Hyaluronan is a very efficient network-forming polymer. Biochem J (1991) 1.69

Genetic testing is important in families with a history suggestive of hereditary non-polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled. Br J Surg (1997) 1.66

Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. J Cardiovasc Surg (Torino) (1997) 1.64

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60

The FDA report on intraocular lenses. Ophthalmology (1983) 1.60

Efficacy of neonatal ocular prophylaxis for the prevention of chlamydial and gonococcal conjunctivitis. N Engl J Med (1989) 1.59

Wilson's disease: presymptomatic patients and Kayser-Fleischer rings. Ophthalmic Genet (1997) 1.58

Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation. Hum Mol Genet (1996) 1.57

LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome. J Med Genet (2006) 1.56

Problem drinking from young adulthood to adulthood: patterns, predictors and outcomes. J Stud Alcohol (1999) 1.54

Differential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma. J Clin Pathol (1999) 1.54

IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab (2001) 1.53

Cancer mortality in the United Kingdom: projections to the year 2025. Br J Cancer (2008) 1.52

Germline PTEN mutations in Cowden syndrome-like families. J Med Genet (1998) 1.51

Testicular feminization in a cat. J Am Vet Med Assoc (1989) 1.51

Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients. Arch Neurol (1994) 1.51

Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas. Proc Natl Acad Sci U S A (2002) 1.51

Comparison of enzyme immunoassay and culture for diagnosis of chlamydial conjunctivitis and respiratory infections in infants. J Clin Microbiol (1987) 1.49

The effects of self-hypnosis on quality of life following coronary artery bypass surgery: preliminary results of a prospective, randomized trial. J Altern Complement Med (1995) 1.49

Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome. Cancer Res (1997) 1.47

Limiting photoreceptor death and deconstruction during experimental retinal detachment: the value of oxygen supplementation. Am J Ophthalmol (1999) 1.47

Sampling methods for cervical smears. Acta Cytol (1992) 1.45

Exserohilum: an emerging human pathogen. Eur J Clin Microbiol Infect Dis (2006) 1.45

The impact of Jade Goody's diagnosis and death on the NHS Cervical Screening Programme. J Med Screen (2012) 1.44

Neurotics who fail to take their drugs. Br J Psychiatry (1965) 1.44

Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Genes Chromosomes Cancer (1998) 1.43

PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J Cell Sci (2001) 1.42

Three years of experience with prospective randomized effectiveness studies. Control Clin Trials (1998) 1.42

Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut (2004) 1.42

Interlaboratory concordance of DNA sequence analysis to detect reverse transcriptase mutations in HIV-1 proviral DNA. ACTG Sequencing Working Group. AIDS Clinical Trials Group. J Virol Methods (1998) 1.41

Exposure to the sun and sunbeds and the risk of cutaneous melanoma in the UK: a case-control study. Eur J Cancer (2004) 1.40

Cognitive impairments in abstinent alcoholics. West J Med (1990) 1.40

Side effects of phenobarbital in toddlers; behavioral and cognitive aspects. J Pediatr (1979) 1.39

Stress, health and disease. Br J Hosp Med (1993) 1.39

Phenotypic expression in familial adenomatous polyposis: partial prediction by mutation analysis. Gut (1994) 1.39

Exonic STK11 deletions are not a rare cause of Peutz-Jeghers syndrome. J Med Genet (2006) 1.39

Molecular classification and genetic pathways in hyperplastic polyposis syndrome. J Pathol (2007) 1.38

DESTRUCTION OF RED BLOOD CELLS AFTER FAT INGESTION. Science (1943) 1.38

How reliable is the allopurinol load in detecting carriers for ornithine transcarbamylase deficiency? J Inherit Metab Dis (2004) 1.38

Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab (1993) 1.38

Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer (2009) 1.38

Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J Antimicrob Chemother (2008) 1.37

Limiting the proliferation and reactivity of retinal Müller cells during experimental retinal detachment: the value of oxygen supplementation. Am J Ophthalmol (1999) 1.37

Ingested arsenic, keratoses, and bladder cancer. Am J Epidemiol (1992) 1.37

Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC. Proc Natl Acad Sci U S A (2002) 1.36

Genetics of risk factors for melanoma: an adult twin study of nevi and freckles. J Natl Cancer Inst (2000) 1.34

The risk of subsequent primary cancers after colorectal cancer in southeast England. Gut (2002) 1.34

Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut (2000) 1.34

Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. Br J Cancer (2003) 1.33

Stimulation of splenic antigen uptake and of antibody response in mice by India ink or other "blockading" agents. Immunology (1966) 1.33